Wachholz, Vanessa
Mustafa, Al-Hassan M. http://orcid.org/0000-0002-4453-2573
Zeyn, Yanira
Henninger, Sven J.
Beyer, Mandy
Dzulko, Melanie
Piée-Staffa, Andrea
Brachetti, Christina
Haehnel, Patricia S.
Sellmer, Andreas
Mahboobi, Siavosh
Kindler, Thomas
Brenner, Walburgis http://orcid.org/0000-0002-1511-6212
Nikolova, Teodora
Krämer, Oliver H. http://orcid.org/0000-0003-3973-045X
Funding for this research was provided by:
deutsche forschungsgemeinschaft (KR 2291)
brigitte und dr. konstanze wegener-stiftung (65)
Johannes Gutenberg-Universität Mainz
Article History
Received: 21 June 2021
Accepted: 29 September 2021
First Online: 19 October 2021
Declarations
:
: OHK AS, SM, TK, MB declare the patent “Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) inhibitors, WO2019/034538”. OHK, AS, SM declares the patent “Novel HDAC6 inhibitors and their uses, WO2016020369A1”. These patents cover substances that were used to collect data that are shown in this article.